Ukrainian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of Pharmacy and Pharmacology 2016-May

The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.

Тільки зареєстровані користувачі можуть перекладати статті
Увійти Зареєструватися
Посилання зберігається в буфері обміну
Kentaro Igami
Masatoshi Ozawa
Sae Inoue
Daisuke Iohara
Toshitsugu Miyazaki
Masamitsu Shinoda
Makoto Anraku
Fumitoshi Hirayama
Kaneto Uekama

Ключові слова

Анотація

OBJECTIVE

20S-protopanaxadiol 20-O-β-D-glucopyranoside (compound K), a metabolite of ginsenoside, is only sparingly soluble in water. The aim of this study was to improve the low solubility, slow dissolution rate and low oral bioavailability of compound K by forming an inclusion complex with γ-cyclodextrin (γ-CyD), and to compare the results with those of β-CyD complex.

METHODS

The interactions of compound K with β and γ-CyDs were studied by the solubility method and proton nuclear magnetic resonance spectroscopy. Solid forms of compound K/CyD complexes with different molar ratios were prepared by the kneading method, and the resulting complex was characterized by powder X-ray diffractometry. The dissolution rate of the complexes was measured by the rotary disk method. In-vivo absorption studies in rats were carried out, and the serum level of compound K, after its oral administration, was measured by a liquid chromatography-tandem mass spectrometry system.

RESULTS

γ-CyD markedly improved the low solubility of compound K at lower CyD concentrations (<0.03 M), whereas the solubility was decreased at higher concentrations (>0.06 m). The enhancement in solubility by γ-CyD at a lower concentration was much higher than the corresponding values for β-CyD. The apparent 1:1 stability constant (1.5 × 10(5) m(-1) ) for the γ-CyD complex was 18-fold larger than that (8.2 × 10(3) m(-1) ) of the β-CyD complex. The dissolution rate of the 1:1 compound K/γ-CyD complex was faster than that for the 1:3 (guest : host) complex. These results suggest that the dissolution rate of the 1:1 complex, in which the drug is partially included, was faster than that of the 1:3 complex, in which the drug was completely included, due to the higher solubility and amorphous property of the former complex compared with the properties of the latter complex. The fast dissolution of the γ-CyD complex was reflected in the maximum plasma level (Cmax ) of the drug and the time (Tmax ) to reach the maximum plasma level after its oral administration to rats.

CONCLUSIONS

The effect of γ-CyD on enhancing the solubility of compound K is much higher than that for the β-CyD complex, and the dissolution rate of the guest when it is partially included in the γ-CyD is faster the corresponding value when it is completely included in the cavity.

Приєднуйтесь до нашої
сторінки у Facebook

Найповніша база даних про лікарські трави, підкріплена наукою

  • Працює 55 мовами
  • Лікування травами за підтримки науки
  • Розпізнавання трав за зображенням
  • Інтерактивна GPS-карта - позначайте трави на місці (скоро)
  • Читайте наукові публікації, пов’язані з вашим пошуком
  • Шукайте лікарські трави за їх впливом
  • Організуйте свої інтереси та будьте в курсі новинних досліджень, клінічних випробувань та патентів

Введіть симптом або хворобу та прочитайте про трави, які можуть допомогти, наберіть траву та ознайомтесь із захворюваннями та симптомами, проти яких вона застосовується.
* Вся інформація базується на опублікованих наукових дослідженнях

Google Play badgeApp Store badge